Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocet and Gemzar in Platinum-Resistant Ovarian Cancer
NCT01100372Phase 2Unknown
- Sponsor
- Medical University of Innsbruck
- Start
- Jul 2009
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in ovarian epithelial cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Medical University of Innsbruck. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
ovarian epithelial cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01100372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100372.